7-ketocholesterol Targeting
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
84
NCT06813339
Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Patients
Phase: Early Phase 1
Role: Lead Sponsor
Start: Feb 25, 2025
Completion: Jun 30, 2026
Loading map...